Rituximab
Rituximab is a chimeric monoclonal antibody that targets the CD20 antigen expressed on the surface of B cells. It is commonly used in various research applications, such as flow cytometry, immunoprecipitation, and immunohistochemistry, to study B cell biology and function.
Lab products found in correlation
4 protocols using rituximab
Cytokine and Antibody Profiling Protocol
Anti-CD20 Antibody Comparative Study
The following anti-CD20 antibodies were used: rituximab and obinutuzumab (Roche), ofatumumab (GSK) and rituximab isotypes (anti-hCD20 isotype collection, InvivoGen). Details of the antibodies used are included in the supplemental methods.
Quantifying Serum Levels of Biotherapeutics
Antibody Characterization for Immunotherapy
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!